logo
OB:AKBM logo

Aker BioMarine Community

OB:AKBM Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 11 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

AKBM logo
Aker BioMarine
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts

Lysoveta Trials And Houston Restructuring Will Expand Omega-3 Reach

Key Takeaways Expanding Omega-3 market share, new products, and major retail partnerships could significantly boost revenue and sales volumes. Centralizing resources and managing tariffs are expected to improve efficiency, reduce costs, and preserve net margins.
View narrative
NOK 55.50
FV
7.0% overvalued intrinsic discount
10.66%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
11 days ago author updated this narrative